Herpes simplex virus type 2 antibody detection performance in Kisumu, Kenya, using the HerpeSelect ELISA, Kalon ELISA, Western blot and inhibition testing

Sexually Transmitted Infections

Volumn 85, Issue 2, 2009, Pages 92-96

  Smith, J S ^a,h   Bailey, R C ^b   Westreich, D J ^a   Maclean, I ^c   Agot, K ^d   Ndinya Achola, J O ^e   Hogrefe, W ^f   Morrow, R A ^g   Moses, S ^b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c UNIVERSITY OF MANITOBA   (Canada)

^d UNIM Project   (Kenya)

^e UNIVERSITY OF NAIROBI   (Kenya)

^f Focus Diagnostics Inc   (United States)

^g UNIVERSITY OF WASHINGTON   (United States)

^h University of North Carolina at Chapel Hill   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GEOGRAPHIC DISTRIBUTION; HERPES SIMPLEX VIRUS 2; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; KENYA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY; SEROPREVALENCE; UNITED STATES; VIRUS DETECTION; WESTERN BLOTTING;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; BLOTTING, WESTERN; CIRCUMCISION, MALE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HIV SERONEGATIVITY; HUMANS; IMMUNOGLOBULIN G; KENYA; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; YOUNG ADULT;

EID: 65649096932     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sti.2008.031815     Document Type: Article

References (16)

1. Freeman E. E. Weiss H. A. Glynn J. R. et al. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 2006; 20: 73-83.
2. van Dyck E. Buve A. Weiss H. A. et al. Performance of commercially available enzyme immunoassays for detection of antibodies against herpes simplex virus type 2 in African populations. J Clin Microbiol 2004; 42: 2961-5.
3. Laeyendecker O. Henson C. Gray R. H. et al. Performance of a commercial, typespecific enzyme-linked immunosorbent assay for detection of herpes simplex virus type 2-specific antibodies in Ugandans. J Clin Microbiol 2004; 42: 1794-6.
4. Hogrefe W. Su X. Song J. et al. Detection of herpes simplex virus type 2-specific immunoglobulin G antibodies in African sera by using recombinant gG2, Western blotting, and gG2 inhibition. J Clin Microbiol 2002; 40: 3635-40.
5. Ashley-Morrow R. Krantz E. Wald A. Time course of seroconversion by HerpeSelect ELISA after acquisition of genital herpes simplex virus type 1 (HSV-1) or HSV-2. Sex Transm Dis 2003; 30: 310-14.
6. Bailey R. Moses S. Parker C. et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 2007; 369: 643-56.
7. Ashley-Morrow R. Nollkamper J. Robinson N. J. et al. Performance of focus ELISA tests for herpes simplex virus type 1 (HSV-1) and HSV-2 antibodies among women in ten diverse geographical locations. Clin Microbiol Infect 2004; 10: 530-6.
8. Lasko T. Bhagwat J. Zou K. et al. The use of receiver operating characteristic curves in biomedical informatics. J Biomed Inform 2008; 38: 404-15.
9. Yan G. Greene T. Links investigating the effects of ties on measures of concordance. Stat Med 2008; 27: 4190-206.
10. Mark H. Nanda J. P. Robert J. et al. Performance of focus ELISA tests for HSV-1 and HSV-2 antibodies among university students with no history of genital herpes. Sex Transm Dis 2007; 34: 681-5.
11. Ngo T. D. Laeyendecker O. La H. et al. Use of commercial enzyme immunoassays to detect antibodies to the herpes simplex virus type 2 glycoprotein G in a low-risk population in Hanoi, Vietnam. Clin Vaccine Immunol 2008; 15: 382-4.
12. Nascimento M. C. Ferreira S. Sabino E. et al. Performance of the HerpeSelect (Focus) and Kalon enzyme-linked immunosorbent assays for detection of antibodies against herpes simplex virus type 2 by use of monoclonal antibody-blocking enzyme immunoassay and clinicovirological reference standards in Brazil. J Clin Microbiol 2007; 45: 2309-11.
13. Lorincz A. Smith J. S. Sexually Transmissible Viral Pathogens: The Human Papillomaviruses and Herpes Viruses. In: Lorincz A. ed. Nucleic Acid Testing for Human Disease. London: Taylor and Francis; 2006: 243-73.
14. Ashley R. L. Type-specific antibodies to HSV-1 and -2: review of methodology. Herpes 1998; 5: 33-8.
15. Hogrefe W. Su X. Song J. et al. Detection of herpes simplex virus type 2-specific immunoglobulin G antibodies in African sera by using recombinant gG2, Western blotting, and gG2 inhibition. J Clin Microbiol 2002; 40: 3635-40.
16. Benson J. A. Karash-Mizrachi I. Lipman D. J. et al. GenBank. Nucleic Acids Res 2007; 35: D21-5.